Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Unit price / market price
-
$1.13
-
Total 13F principal
-
$201,310,000
-
Principal change
-
+$2,197,000
-
Total reported value
-
$227,670,676
-
Number of holders
-
30
-
Value change
-
+$3,488,981
-
Number of buys
-
13
-
Number of sells
-
18
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q3 2016
As of 30 Sep 2016 AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 had 30 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $201,310,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included STELLIAM INVESTMENT MANAGEMENT, LP, FMR LLC, WOLVERINE ASSET MANAGEMENT LLC, Birch Grove Capital LP, STEELHEAD PARTNERS LLC, CITADEL ADVISORS LLC, CREDIT SUISSE AG/, CALAMOS ADVISORS LLC, LINDEN ADVISORS LP, and LAZARD ASSET MANAGEMENT LLC.
This table shows 30 bond principal holders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.